{"schema_version":"secwatch.filing_event.v1","accession":"0001846253-25-000064","form_type":"8-K","ticker":"OABI","cik":"0001846253","company_name":"OmniAb, Inc.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.331600+00:00","generated_at":"2026-05-17T19:56:14.126111+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"OmniAb reports Q2 2025 revenue $3.9M, net loss $15.9M; affirms $20-25M FY revenue guidance","bullets":["Q2 revenue $3.9M (down 49% YoY) on lower milestone and service revenue; net loss $15.9M ($0.15/sh) vs $13.6M ($0.13) in Q2 2024.","2025 guidance: revenue $20M-$25M, operating costs $85M-$90M, cash use expected below 2024's $38.9M (ex-ATM).","100 active partners and 381 active programs as of June 30, 2025, including 32 OmniAb-derived programs in clinical development.","Sold small-molecule Kv7.2 program to Angelini Pharma for $3M upfront; eligible for >$170M milestones plus royalties.","Launched xPloration Partner Access Program for high-throughput B-cell screening; xPloration won 2025 Best of Show at PEGS Boston."],"urls":{"canonical":"https://secwatch.observer/filing/0001846253-25-000064","json":"https://secwatch.observer/filing/0001846253-25-000064.json","markdown":"https://secwatch.observer/filing/0001846253-25-000064.md","text":"https://secwatch.observer/filing/0001846253-25-000064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1846253/000184625325000064/0001846253-25-000064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1846253/000184625325000064/oabi-20250806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:56:14.126111+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}